- Home
- STRO vs WHF Comparison
STRO vs WHF Comparison
Compare STRO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- WHF
- Stock Information
- Founded
- STRO 2003
- WHF 2011
- Country
- STRO United States
- WHF United States
- Employees
- STRO N/A
- WHF N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- WHF Finance Companies
- Sector
- STRO Health Care
- WHF Finance
- Exchange
- STRO Nasdaq
- WHF Nasdaq
- Market Cap
- STRO 74.3M
- WHF 207.1M
- IPO Year
- STRO 2018
- WHF 2012
- Fundamental
- Price
- STRO $0.90
- WHF $8.80
- Analyst Decision
- STRO Hold
- WHF Hold
- Analyst Count
- STRO 7
- WHF 4
- Target Price
- STRO $1.97
- WHF $10.00
- AVG Volume (30 Days)
- STRO 520.3K
- WHF 76.3K
- Earning Date
- STRO 11-12-2025
- WHF 11-06-2025
- Dividend Yield
- STRO N/A
- WHF 20.33%
- EPS Growth
- STRO N/A
- WHF N/A
- EPS
- STRO N/A
- WHF 0.15
- Revenue
- STRO $104,473,000.00
- WHF $81,499,000.00
- Revenue This Year
- STRO $65.48
- WHF N/A
- Revenue Next Year
- STRO N/A
- WHF N/A
- P/E Ratio
- STRO N/A
- WHF $57.37
- Revenue Growth
- STRO N/A
- WHF N/A
- 52 Week Low
- STRO $0.52
- WHF $8.36
- 52 Week High
- STRO $4.60
- WHF $12.33
- Technical
- Relative Strength Index (RSI)
- STRO 49.98
- WHF 58.25
- Support Level
- STRO $0.83
- WHF $8.70
- Resistance Level
- STRO $1.01
- WHF $8.97
- Average True Range (ATR)
- STRO 0.09
- WHF 0.11
- MACD
- STRO -0.01
- WHF 0.03
- Stochastic Oscillator
- STRO 19.40
- WHF 66.67
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.